Suppr超能文献

BH3 模拟肽:一种补充抗癌疗法的有效策略。

BH3 Mimetic Peptides: An Effective Strategy to Complement Anticancer Therapy.

机构信息

Department of Biomedical Science, Bharathidasan University, Tiruchirappalli, 620 024, Tamil Nadu, India.

Department of Biomedical Science, Cancer Genetics and Nanomedicine Laboratory, Bharathidasan University, Tiruchirappalli, 620 024, Tamil Nadu, India.

出版信息

Curr Protein Pept Sci. 2023;24(10):853-864. doi: 10.2174/1389203724666230822100131.

Abstract

Apoptosis, a natural process of programmed cell death, is a promising therapeutic target as the disruption of apoptosis evolves in many diseases including cancer. Several pieces of evidence indicate that errors in apoptotic pathways result in the imbalance between cell proliferation and death, allowing cells with genetic abnormalities to survive. The intrinsic and extrinsic pathways of apoptosis utilize different caspases to execute the event of cell death through the cleavage of hundreds of proteins. Proteins from the Bcl-2 family, a pivotal component of the mitochondrial apoptosis pathway, activate the death signal either directly or indirectly involving mitochondrial translocation of Bax/Bak, which are recognized critical elements in defective apoptosis. The majority of chemotherapeutic drugs destroy cancer cells by activating the apoptotic machinery via Bcl-2/Bax-dependent process and failure of which leads to an intrinsic chemoresistance. Recent insights into the dynamic action of pro-survival Bcl-2 proteins in cancer pathogenesis and resistance has set the stage for the development of small molecules as Bcl-2 antagonist and modulators of apoptosis. The BH3-only proteins are vital inducers of the mitochondrial apoptosis mechanism that operate either by assuming the functional activity of the proapoptotic Bcl-2 family members or by impeding the antiapoptotic Bcl-2 proteins. Based on the structural interaction studies between the proapoptotic and anti-apoptotic proteins, several synthetic peptides have been designed to functionally mimic the BH3 domain, targeting directly the pro-survival Bcl-2 proteins. The "BH3-peptide mimetics" a novel class of Bcl-2 protein antagonists essentially play an important role in the treatment of malignancies as they are predicted to persuade non-receptor mediated programmed cell death. This review summarizes the most promising BH3-peptide mimetic compounds that function as selective antagonists of Bcl-2 proteins and would be effective in treating various cancers.

摘要

细胞凋亡是一种程序性细胞死亡的自然过程,作为许多疾病(包括癌症)中凋亡紊乱的治疗靶点具有广阔的前景。有几项证据表明,凋亡途径中的错误导致细胞增殖和死亡之间的失衡,从而使具有遗传异常的细胞得以存活。细胞凋亡的内在和外在途径利用不同的半胱氨酸蛋白酶来执行细胞死亡事件,通过切割数百种蛋白质。Bcl-2 家族的蛋白质是线粒体凋亡途径的关键组成部分,通过直接或间接涉及 Bax/Bak 的线粒体易位来激活死亡信号,Bax/Bak 被认为是凋亡缺陷的关键因素。大多数化疗药物通过 Bcl-2/Bax 依赖性途径激活凋亡机制来破坏癌细胞,如果该途径失效,则会导致内在的化疗耐药性。最近对生存 Bcl-2 蛋白在癌症发病机制和耐药性中的动态作用的深入了解,为开发 Bcl-2 拮抗剂和凋亡调节剂等小分子奠定了基础。BH3-仅有蛋白是线粒体凋亡机制的重要诱导剂,它们通过承担促凋亡 Bcl-2 家族成员的功能活性或阻止抗凋亡 Bcl-2 蛋白来发挥作用。基于促凋亡和抗凋亡蛋白之间的结构相互作用研究,已经设计了几种合成肽来模拟 BH3 结构域的功能,直接靶向生存 Bcl-2 蛋白。“BH3-肽模拟物”是一类新型的 Bcl-2 蛋白拮抗剂,它们在治疗恶性肿瘤方面发挥着重要作用,因为它们有望促使非受体介导的程序性细胞死亡。本综述总结了最有前途的 BH3-肽模拟化合物,它们作为 Bcl-2 蛋白的选择性拮抗剂,将有效地治疗各种癌症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验